Bone drug has benefits in cancer patients
July 18, 2008 — NEW YORK (Reuters Health) - The bone-strengthening drug zoledronic acid not only reduces fracture risk in patients with cancer that has spread to the bones, it also improves overall survival, according to the results of a retrospective analysis of three large studies.
Thickness of Squamous Cell Cancer Associated with Risk of Recurrences
July 18, 2008 — The thickness of squamous cell carcinoma (SCC) of the skin is directly related to the risk of recurrences. These results were recently published in Lancet Oncology.
"Emotional" writing may help ease cancer pain
July 18, 2008 — NEW YORK (Reuters Health) - Some cancer patients may find that putting their emotions down in writing helps improve their pain and general well-being, a study suggests.
Select news items provided by Reuters Health